Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Julphar
Healthtrust
Deloitte
Johnson and Johnson
QuintilesIMS
Boehringer Ingelheim
Fish and Richardson
Citi
Cipla

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,629,327

« Back to Dashboard

Summary for Patent: 5,629,327
Title: Methods and compositions for inhibition of angiogenesis
Abstract:The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.
Inventor(s): D'Amato; Robert (Lancaster, PA)
Assignee: Childrens Hospital Medical Center Corp. (Boston, MA)
Application Number:08/168,817
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,629,327

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,629,327

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 218865 ➤ Subscribe
Austria 304356 ➤ Subscribe
Australia 6248694 ➤ Subscribe
Australia 676722 ➤ Subscribe
Brazil 9400764 ➤ Subscribe
Canada 2157288 ➤ Subscribe
Canada 2342974 ➤ Subscribe
Canada 2512926 ➤ Subscribe
Colombia 4230017 ➤ Subscribe
Germany 122008000044 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Chubb
Healthtrust
QuintilesIMS
Fuji
McKesson
Accenture
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot